ANTIARRHYTHMIC DRUGS. Every hour 2000 patients around the world die from sudden arrhythmia attack.
-
Upload
poppy-stanley -
Category
Documents
-
view
216 -
download
2
Transcript of ANTIARRHYTHMIC DRUGS. Every hour 2000 patients around the world die from sudden arrhythmia attack.
Extrasystolia, scintillating arrhythmia, Extrasystolia, scintillating arrhythmia, paroxysmal tachycardia, fibrillationparoxysmal tachycardia, fibrillation
Causes Mechanisms
Surplus of catecholamines (thyreotoxicosis)
Increasing of frequency of spontaneous diastolic depolarization (calcium type) in Р-cells of sinus node
Disturbance of ion balance (hypopotassiumemia, hypomagnesiumemia), ischemia, hypoxia of myocardium, intoxication (cardiac glycosides)
Development of sodium ("fast") type of spontaneous depolarization in elements of conductive system of the heart which don’t have automatism in normal conditions
Insufficient power of potential which exits from sinus node
Manifestation of activity of heterotopous source of impulse development
Disturbance of conductivity Local circulation of impulses(re-entry mechanism)
Scheme of mechanism of repeated entryScheme of mechanism of repeated entry
norm
Nervous impulse
Wall of the ventricles
Impulse goes in reverse direction and enters the starting point (circulation of the impulse),
which leads to out of order and non regular contraction of the heart
12
One-side blockade
Arrhythmia riskier in athletesArrhythmia riskier in athletes
Cardiac problems like Cardiac problems like an abnormal an abnormal heartbeat are heartbeat are exacerbated by exacerbated by rigorous exercise in a rigorous exercise in a way that can be fatal way that can be fatal in athletes, and in athletes, and regular testing for the regular testing for the problem could save problem could save liveslives
Drugs can provoke arrhythmias Drugs can provoke arrhythmias (arrhythmogenic action)(arrhythmogenic action)
All antiarrhythmics All antiarrhythmics except beta-except beta-adrenoblockersadrenoblockers
AntidepressantsAntidepressants
AdrenomimeticsAdrenomimetics
Some antiallergics Some antiallergics (terfenadine=telfast)(terfenadine=telfast)
Classification of antiarrhythmic drugs accordingly Classification of antiarrhythmic drugs accordingly to Williams and Harrison (1970, 1981)to Williams and Harrison (1970, 1981)
Class Mechanism of action Drugs
II Membrane stabilizing, sodium canals blockers
I АI А Slow down Na+ ions entry into cells moderately (0-phase of action potential), considerably prolong (during phase 3) action potential and repolarization duration
Chinidine, novocainamid, disopyramid, aimalin, imipramin, primalin etc.
I BI B Weakly influence on Na+ ions entry, shorten repolarization duration and action potential
Lidocain, trimecain, mexyletin, tokainid, difenin
I СI С Considerably depress Na+ ions entry but almost don’t influence on repolarization period and action potential duration
Flecainid, encainid, ethmosin, ethacisin, alapinin, propaphenon
IIII Beta-adrenergic receptors blockers Anaprilin, nadolol, esmolol, atenolol, methoprolol, bisoprolol
IIIIII Prolong repolarization and action potential (potassium canals blockers)
Amiodaron, brethylium, d-sotalol, nibentan etc.
IVIV Calcium canals blockers Verapamil, galopamil, dilthiazem, bepridil
5th Bradycardiaс agents Alinidin
6th Purinergic receptors stimulants Adenosine, ATP
Indications for using Chinidine sulfateChinidine sulfate (I-А class)
Stabile form of scintillating arrhythmia
Stopping of scintillating arrhythmia
paroxysms
Ventricular extrasystolia and tachycardia (rarely)
Supporting of normal rhythm after cardio version (electro-impulse therapy)
Complications Complications оf chinidine sulfatechinidine sulfate
1. Sinus bradycardia2. Cardiac insufficiency
3. Pirouette tachycardia (“torsade de points” -
polymorphic ventricular tachycardia)4. Thromboembolia
5. Hypotension 6. Nausea, vomiting
7. Ringing in ears, hearing disorders8. Eyesight (vision) disorders
9. Skin rash10. Agranulocytosis (bone marrow suppression)
11. Hepatitis etc.
Indications for administration ofNovocain amidNovocain amid (I-А class)
1. Paroxysms of scintillating arrhythmia (in a case when verapamilum and ATP are ineffective)
2. Fibrillation of atria
3. Prophylaxis and treatment of paroxysmal ventricular tachycardia, extrasystolia
• Allergic reactions (cross-allergic reactions with other Allergic reactions (cross-allergic reactions with other drugs of PABA structure)drugs of PABA structure)
• Nausea, vomitingNausea, vomiting• Insomnia, headache Insomnia, headache
• SeizuresSeizures•Arterial hypotensionArterial hypotension
• Disorders of conductivity and contractility of Disorders of conductivity and contractility of myocardium myocardium
• Arrhythmogenic actionArrhythmogenic action• Leukopenia, agranulocytosisLeukopenia, agranulocytosis• Symptoms of system lupusSymptoms of system lupus
Complications Complications of of novocainamidnovocainamid
Indications for administration
Lidocain (I В class)Lidocain (I В class)
It is a drug of choice in case of heavy ventricular
arrhythmias (extrasystolia, paroxysmal tachycardia,
fibrillation) of different origin, including acute
myocardial infarction (0,2 % sol. i. v. very slowly)
Difenin (I В class)Difenin (I В class)
To treat tachyarrhythmias caused by intoxication
with cardiac glycosides
Antiarrhythmic drugs of І С class
ethmosin ethacysin
Atrial and ventricular paroxysmal tachycardia, extrasystolia
Ventriculartachyarrhythmias
Nowadays it is recommended to limit administration of 1 C class drugs using only for the most life threatening
ventricular arrhythmias with considerable clinical symptoms
-adrenoblockers (II class)
(anaprilin, atenolol, methoprolol)(anaprilin, atenolol, methoprolol)
Administration: sinus tachycardia (for thyrotoxicosis), supraventricular extrasystolia, paroxysmal tachycardia, including acute myocardial infarction
Contraindications:Contraindications: bronchial asthma, diabetes mellitus, diseases of peripheral vessels, atrioventricular blockade
Potassium canals blockers (III class)Potassium canals blockers (III class)
(amiodaron, brethylium, sotalol)
Usage: atrial and ventricular tachyarrhythmias
AmiodaronAmiodaron drug of choice in case of drug of choice in case of paroxysmal scintillating paroxysmal scintillating
arrhythmia and malignant arrhythmia and malignant ventricular disorders of rhythmventricular disorders of rhythm
Scheme of amiodaron administration
І - Saturation period (1,5-2 weeks):
200 mg 2-3 times daily
ІІ – Supporting therapy:
200 mg daily 5 days, 2-days brake, after - a certain period of time accordingly to this scheme
Calcium canals blockers (IV class)Calcium canals blockers (IV class)
(verapamil, dilthiazem)
Administration
supraventricular tachyarrhythmias supraventricular tachyarrhythmias
(paroxysmal tachycardia, extrasystolia, (paroxysmal tachycardia, extrasystolia,
scintillating arrhythmia)scintillating arrhythmia)
VerapamilumVerapamilum
Combination of Combination of verapamilum verapamilum and and digoxinum digoxinum can cause acute digoxine intoxication (they can cause acute digoxine intoxication (they compete for binding with plasma proteins)compete for binding with plasma proteins)
I.v. I.v. verapamileverapamile introduction on the basis of introduction on the basis of ββ-adrenoblockers-adrenoblockers administration can provoke administration can provoke severe bradycardia, severe bradycardia, heart blockade and acute heart blockade and acute hypotensionhypotension
ADENOSINTRIPHOSPHATE (ATP)ADENOSINTRIPHOSPHATE (ATP)
AdministrationAdministration – – supraventricular arrhythmias supraventricular arrhythmias
(i. v. by bolus)(i. v. by bolus)
ComplicationsComplications
ATP introduction after ATP introduction after ββ-adrenoblockers -adrenoblockers can provoke syno-atrial node depression and can provoke syno-atrial node depression and even cardiac arresteven cardiac arrest
When vasospastic type of IHD – ATP When vasospastic type of IHD – ATP introduction can lead to severe angina attackintroduction can lead to severe angina attack
Specific antagonist of ATP - theophyllineSpecific antagonist of ATP - theophylline
Choice of antiarrhythmic agent depending on kind of tachyarrhythmia
• supraventricular tachyarrhythmiassupraventricular tachyarrhythmias – verapamil, beta-adrenoblockers, cardiac glycosides
• ventricular tachyarrhythmiasventricular tachyarrhythmias – lidocain, trimecain, mexyletin, phenitoin (diphenin), ornide, flecainid, rhythmilen
• effective in both caseseffective in both cases - for supraventricular and ventricular tachyarrhythmias – chinidine, novocainamid, ethmosyn, ethacysyn, amiodaron, sothalol, potassium preparates
Administration of antiarrhythmic drugs due to life-threatening
indications
1. frequent and polytopic extrasystoles – manifestations of possible fibrillation
2. constant and paroxysmal ventricular
tachycardia
3. fibrillation of ventricles
4. atrial rhythm disorders, if accompanied by considerable haemodynamic disorders
Administration of antiarrhythmic drugs
Class IType of
arrhythmia
Atrium arrhythmia
Fibrillationof atria
chinidine
amiodaron
anaprilin verapamil digoxin
anticoagulant therapy
The most widely used drug The alternative drug
Class II Class III Class IV others
!This arrhythmia is accompanied by multiple ectopic seats of impulses in atria, which leads to increasing of frequency of ventricular contractions (100-150 beats per minute), which becomes irregular
Antiarrhythmic drugs
Scintillation of atria
Beta-blockers – are the drugs of choicein case of atria fibrillation.
Long lasting administration of anticoagulants in small doses decreases
risk of stroke associated withfibrillation of atria
lidocain
anaprilin
Supraventriculartachycardias
Mechanism ofreentry
Acute supraventricular
tachycardia
anaprilin verapamil digoxin
verapamil adenosine
CONDUCTION OF IMPULSE THROUGH ATRIO-
VENTRICULAR NODE CAN BE SLOWED DOWN BY:
ANAPRILIN, VERAPAMIL,
DIGOXIN
Ventricular tachycardias
Acuteventricular tachycardia
Fibrillation ofventricles
(the previous defibrillation is
not effective)
lidocain
Sotalol,amiodaron
brethylium,amiodaron
adrenalin
This arrhythmia is an often cause of deathof patinets with myocardium infarction.
It can be quickly transformed into fibrillation of ventricles. It needs an immediate treatment.
chinidine
Influence of prolonged administration of antiarrhythmic drugs on mortality
(results of placebo-controlled multicenter randomized trials)
mortality increasingincreasing
mortality decreasingdecreasing
Can possibly decrease mortality (modern data is not convincing)
encainidflecainidmoracisin
beta-adrenoblockers
amiodarondysopyramidmexylethyn
novocainamidpropaphenon
chinidinesotalol
?
MANAGEMENT of ATRIOVENTRICULAR MANAGEMENT of ATRIOVENTRICULAR BLOCKADEBLOCKADE
M-cholinoblockers (atropine)M-cholinoblockers (atropine)
ββ-adrenomimetics -adrenomimetics ((isadrineisadrine))
GlucagonGlucagon
Calcium preparationsCalcium preparations